You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 10/24/2014

Company Name Symbol %Change
STRATTEC SEC STRT
13.65%
BIODEL INC BIOD
13.24%
PACIFIC BIOS PACB
7.24%
BRAINSTORM C BCLI
6.69%
CENTURY ALUM CENX
6.20%
Mesa Labs Reports Quarterly Dividend

Print Share

Nov 15, 2012 (Close-Up Media via COMTEX) -- Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.14 per share of common stock, up from $0.13 per share last quarter.

According to a release, the dividend will be payable December 14, to shareholders of record on November 30.

The increase in the regular quarterly dividend rate from $0.13 to $0.14 per common share represents an eight percent increase from the previous dividend rate, and a 180 percent increase since initiation of the quarterly dividend policy in December 2003.

((Comments on this story may be sent to newsdesk@closeupmedia.com))

Copyright Close-Up Media, Inc. 2012. All Rights reserved

**********************************************************************

As of Sunday, 11-11-2012 23:59, the latest Comtex SmarTrendA? Alert,
an automated pattern recognition system, indicated a DOWNTREND on
03-16-2012 for MLAB @ $53.49.

For more information on SmarTrend, contact your market data
provider or go to www.mysmartrend.com

SmarTrend is a registered trademark of Comtex News Network, Inc.
Copyright A? 2004-2012 Comtex News Network, Inc. All rights reserved.

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

    Zacks Research is Reported On:

    Zacks Investment Research

    is an A+ Rated BBB

    Accredited Business.